---
title: "Bio-Rad Lab (BIO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BIO.US/norm.md"
symbol: "BIO.US"
name: "Bio-Rad Lab"
parent: "https://longbridge.com/en/quote/BIO.US.md"
datetime: "2026-05-20T12:56:51.895Z"
locales:
  - [en](https://longbridge.com/en/quote/BIO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BIO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BIO.US/norm.md)
---

# Bio-Rad Lab (BIO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -19.55 | 26.65 | -12.70 | 11.67 | 2.29 |
| ROE | -29.48% | 40.59% | -19.73% | 18.41% | 3.86% |
| Revenue | 592.10M | 693.20M | 653.00M | 651.60M | 585.40M |
| Net income | -527.10M | 720.00M | -341.90M | 317.80M | 64.00M |
| Operating income | 34.10M | 61.50M | 68.00M | 79.60M | 23.70M |
| Gross margin | 52.25% | 49.74% | 52.50% | 53.01% | 52.27% |
| Net margin | -89.02% | 103.87% | -52.36% | 48.77% | 10.93% |
| Profit quality | 31.54% | 37.30% | 56.24% | 68.33% | 18.24% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 9.79B | 10.58B | 9.70B | 10.21B | 9.53B |
| Leverage | 1.43 | 1.42 | 1.44 | 1.43 | 1.43 |
| BVPS | 255.37 | 276.16 | 249.75 | 263.42 | 241.72 |
| Turnover | 0.2681 | 0.2591 | 0.2520 | 0.2567 | 0.2296 |
| Cash & STI | 1.56B | 1.54B | 1.42B | 1.37B | 1.66B |
| Inv & Rec | 770.50M | 740.70M | 783.20M | 798.80M | 790.10M |
| LT assets | 689.40M | 709.90M | 720.50M | 740.10M | 681.70M |
| Net debt | -186.50M | -155.90M | -23.30M | 32.70M | -290.90M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 108.10M | 164.90M | 120.90M | 116.50M | 129.90M |
| Investing CF | -93.20M | -34.20M | -43.00M | -115.40M | 2.90M |
| Financing CF | -44.00M | 3.30M | -52.50M | -136.30M | -97.70M |
| Free CF | 36.01M | 104.34M | 44.80M | 27.75M | 62.61M |
| OCF coverage | 359.14% | 358.48% | 381.39% | 253.81% | 376.52% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -30.00M | -45.80M | -31.70M | -45.70M | -34.40M |